JACOBS LEVY EQUITY MANAGEMENT, INC
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 884414
FLORHAM PARK, NJ
Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$98,157,217
+$68,176,280 QoQ
Shares Held
2,939,719
+105.4% QoQ
Ownership
2.98%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#9
of 310 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. RARE ranks #2 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
This page
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in RARE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,157,217 | 2,939,719 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,980,937 | 1,431,071 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,233,164 | 1,749,268 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $65,205,288 | 2,167,729 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $11,037,623 | 303,565 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $5,441,678 | 97,960 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,070,839 | 634,327 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $32,104,931 | 687,619 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,381,527 | 718,978 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,676,110 | 748,278 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $27,875,759 | 604,287 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $31,108,577 | 775,775 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $30,627,975 | 661,083 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,146,640 | 220,880 | Shares | Sole | 2022-11-15 | |
| 2021-12-31 | $241,842 | 2,876 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $977,896 | 11,898 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,096,765 | 26,806 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $434,392 | 9,777 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||